4 ms·
Yes, but we've had Ozempic since 2017 for type 2 diabetes. That's longer than Vioxx was on the market.
by ebiester 2y ago
Yes, but we've had Ozempic since 2017 for type 2 diabetes. That's longer than Vioxx was on the market.
- WillPostForFood 2y agoAnd other GLP-1 receptor agonists since 2005 when Exenatide was approved.
- cyberax 2y agoAnd before that, liraglutide. Ozempic (semaglutide) is basically the same drug with some tweaks to extend its half-life.
- throwanem 2y agoGranted, although I might counter that given so broad an apparent increase in the scope of the indication, 2017-2021 (? I can't immediately find a date for Ozempic specifically) and 2021- might best be taken as at least partially distinct. I think that's an argument less well advanced by me than by someone who could design such a study, though, not least because they'll know far better than I whether the proposition makes any real sense.